ITR/NGS: Synthetic Environment for Continuous Experimentation
ITR/NGS: Synthetic Environment for Continuous Experimentation
批准号:
0325846
负责人:
Alok Chaturvedi
金额:
$117.84万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2007-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The study of bio-terror threats require a significant improvement in our capabilities to analyze the human response to an attack, both at the level of the citizens (mobility, infection, and the feeling of well-being) and at the level of responders and policy makers (coordination, control, planning, and policy formulation). This project will address these issues using a geography based synthetic environment with artificial and human agents. Computational models of artificial agents' position, mobility, infection-susceptibility and the state of well-being will be developed. Intuitive interfaces will be provided to human agents to carry out the complex coordination roles. Together, their behaviors will be used to analyze how a bio-terror attack may spread through the population and how its impact might be contained by different intervention strategies. We will use this platform to conduct new and innovative research. The results of such exercises will also be used to help develop, test, analyze, and implement public policies and operating procedures. Once implemented, the models will be extended to include coordination amongst responders in multiple jurisdictions and for multiple pathogens.An important aspect of the work is to develop an agent-based scalable software architecture for tera-scale, grid computing, and to virtually test the prorotype technology and it's effectiveness on heterogeneous resource availability environements requiring real-tim eresponse and heterogeneous platform assemblies comprising of diverse systems, such as GPS, wireless communications, and enabling decisionsupport during crisis situations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSR--CSI: Composing Large-Scale Synthetic Environments through Self-Assembly of Heterogeneous Simulations
-
批准号:0720677
-
项目类别:Standard Grant
-
资助金额:$32.5万
-
财政年份:2007
-
负责人:Alok Chaturvedi
-
依托单位:
Scalable Enterprise Systems Phase II: Agent Based Scalable Enterprise System for Enterprise Co-design
-
批准号:0122214
-
项目类别:Continuing Grant
-
资助金额:$49.84万
-
财政年份:2001
-
负责人:Alok Chaturvedi
-
依托单位:
CISE Next Generation: Scalable Enterprise Systems: An Agent Based Modeling Framework for Scalable Interdependent Markets and Organizations
-
批准号:0075506
-
项目类别:Standard Grant
-
资助金额:$9.95万
-
财政年份:2000
-
负责人:Alok Chaturvedi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NGS结合免疫微环境预测肝癌经动脉灌注化疗栓塞(TACE)联合靶免治疗疗效的研究
-
批准号:2023JJ60305
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:龙林
-
依托单位:
基于NGS的HIV分型及耐药基因检测的多中心临床验证
-
批准号:2023JJ60396
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:郑芳
-
依托单位:
NGS-MHs 分型体系在肿瘤组织个体识别鉴定中的应用探索
-
批准号:2022JJ30343
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:徐伟
-
依托单位:
Alport 综合征新致病基因突变和表观组学的研究及建立以靶向NGS 技术为基础的基因诊断体系
-
批准号:2021JJ70111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:石大志
-
依托单位:
结合NGS技术小分子污染物纳米抗体研制方法的建立及应用
-
批准号:32001066
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王楷
-
依托单位:
ddPCR 和 NGS 动态监测 RAS 和 BRAF 野生型结直肠癌西妥昔单抗治疗过程中ctDNA 变化:耐药机制分析与后线靶向治疗策略
-
批准号:19ZR1472000
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:刘汝娇
-
依托单位:
基于NGS和AAV基因技术的艾灸对APOE-/-小鼠血小板活化的特异性作用及P2Y嘌呤能受体机制研究
-
批准号:81904286
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:杨佳
-
依托单位:
基于肿瘤干细胞与NGS的小细胞肺癌化疗耐药相关分子机制研究
-
批准号:81972199
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:于江泳
-
依托单位:
基于NGS发现滇重楼中新的负链RNA病毒及致病性鉴定
-
批准号:81860774
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2018
-
负责人:赵明富
-
依托单位:
N-乙酰葡糖胺感知因子Ngs1介导的信号途径调控白念珠菌形态发生和致病性的分子机制
-
批准号:31770162
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:逯杨
-
依托单位: